[1] Zhang J, Fan Y, Liang H, et al.Global, regional and national temporal trends in Parkinson's disease incidence, disability-adjusted life year rates in middle-aged and older adults: A cross-national inequality analysis and Bayesian age-period-cohort analysis based on the Global Burden of Disease 2021[J]. Neurol Sci, 2025, 46(4): 1647-1660. [2] Meira B, Lhommée E, Schmitt E, et al.Early Parkinson's disease phenotypes tailored by personality, behavior, and motor symptoms[J]. J Parkinsons Dis, 2022, 12(5): 1665-1676. [3] Rajan S, Kaas B.Parkinson's disease: Risk factor modification and prevention[J]. Semin Neurol, 2022, 42(5): 626-638. [4] 中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍专业委员会. 中国帕金森病的诊断标准(2016版)[J]. 中华神经科杂志,2016,49(4):268-271. [5] 张思婷,王柳森,姜红如,等. 中国四省55岁及以上人群帕金森病前驱症状现状及人口经济学特征[J]. 环境与职业医学,2023,40(2):122-128. [6] 《中国高血压防治指南》修订委员会. 中国高血压防治指南2018年修订版[J]. 心脑血管病防治,2019,19(1):1-44. [7] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志,2021,37(4):311-398. [8] 钟丽,张涛. 饮酒模式的评估及分类[J]. 四川精神卫生,2015,28(5):485-488. [9] 何权瀛,高莹慧. 关于吸烟问题若干名词定义[J]. 中华结核和呼吸杂志,2009,32(1):26. [10] 国家卫生健康委. GBZ 2.1—2019 工作场所有害因素职业接触限值第1部分:化学有害因素[S]. 北京:中国标准出版社,2019. [11] 胡喜庆,张本恕. 帕金森病患者睡眠障碍的临床分析[J]. 国际神经病学神经外科学杂志,2009,36(3):201-205. [12] St Louis EK, Boeve BF.REM sleep behavior disorder: Diagnosis, clinical implications, and future directions[J]. Mayo Clin Proc, 2017, 92(11): 1723-1736. [13] Doty RL, Shaman P, Kimmelman CP, et al.University of Pennsylvania Smell Identification Test: A rapid quantitative olfactory function test for the clinic[J]. Laryngoscope, 1984, 94(2): 176-178. [14] 段泉泉,胜利. 焦虑及抑郁自评量表的临床效度[J]. 中国心理卫生杂志,2012,26(9):676-679. [15] 赵贞贞,林征,林琳,等. 中文版患者便秘状况评估量表在应用评价中的信效度研究[J]. 中华护理杂志,2010,45(12):1124-1126. [16] Freeman R, Wieling W, Axelrod FB, et al.Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome[J]. Clin Auton Res, 2011, 21(2): 69-72. [17] 张唯力,徐光勇,刘川. 勃起功能国际指数-5与夜间阴茎勃起实验在诊断勃起功能障碍中的应用[J]. 中华泌尿外科杂志,2004,25(8):575-577. [18] 贾春松,崔昕,廖利民,等. 帕金森患者下尿路症状的特点[J]. 中华泌尿外科杂志,2017,38(11):811-814. [19] Yazar V, Dawson VL, Dawson TM, et al.DNA methylation signature of aging: Potential impact on the pathogenesis of Parkinson's disease[J]. J Parkinsons Dis, 2023, 13(2): 145-164. [20] de Rijk MC, Breteler MM, Graveland GA, et al. Prevalence of Parkinson’s disease in the elderly: The Rotterdam Study[J]. Neurology, 1995, 45(12): 2143-2146. [21] 廖书胜,陈红,刘玫,等. PRKN基因突变所致早发型帕金森病家系的临床特征及基因检测[J]. 昆明医科大学学报,2023,44(5):66-71. [22] 宋秋霞,刘燕,郭淼,等. 帕金森病患者SEPT14基因多态性与临床症状的关系分析[J]. 脑与神经疾病杂志,2021,29(11):688-693. [23] 李昌龙,冯春莉,孙瑞. 2019—2023年徐州市PM2.5和臭氧复合污染特征分析[J]. 四川环境,2024,43(5):7-14. [24] Atterling Brolin K, Schaeffer E, Kuri A, et al.Environmental risk factors for Parkinson′s disease: A critical review and policy implications[J]. Mov Disord, 2025, 40(2): 204-221. [25] Huang M, Bargues-Carot A, Riaz Z, et al.Impact of environmental risk factors on mitochondrial dysfunction, neuroinflammation, protein misfolding, and oxidative stress in the etiopathogenesis of Par kinson′s disease[J]. Int J Mol Sci, 2022, 23(18): 10808. |